Christian Rummey, John M. Flynn, Louise A. Corben, Martin B. Delatycki, George Wilmot: Scoliosis in Friedreich's ataxia: longitudinal characterization in a large heterogeneous cohort. In: Annals of Clinical and Translational Neurology. Band8, Nr.6, Juni 2021, ISSN2328-9503, S.1239–1250, doi:10.1002/acn3.51352, PMID 33949801.
Artem P. Gureev, Irina S. Sadovnikova, Natalia N Starkov, Anatoly A. Starkov, Vasily N. Popov: p62-Nrf2-p62 Mitophagy Regulatory Loop as a Target for Preventive Therapy of Neurodegenerative Diseases. In: Brain Sciences. 2020, Band 10, Nummer 11, S. 847 DOI:10.3390/brainsci10110847.
Theresa A. Zesiewicz, Joshua Hancock, Shaila Ghanekar, Sheng-Han Kuo, Carlos A. Dohse, Joshua Vega: Emerging therapies in Friedreich’s Ataxia. In: Expert Review of Neurotherapeutics. 2020, Band 20, Nummer 12, S. 1215–1228 doi:10.1080/14737175.2020.1821654.
Myriam Rai, Elisabetta Soragni, C. James Chou, Glenn Barnes, Steve B Jones, James R. Rusche, Joel M. Gottesfeld, Massimo Pandolfo: Two New Pimelic Diphenylamide HDAC Inhibitors Induce Sustained Frataxin Upregulation in Cells from Friedreich's Ataxia Patients and in a Mouse Model. In: PLOS ONE. 2010, Band 5, Nummer 1, S. e8825 doi:10.1371/journal.pone.0008825.
Elisabetta Soragni und Joel M. Gottesfeld: Translating HDAC inhibitors in Friedrich's ataxia. In: Expert Opinion on Orphan Drugs. Band 4, Nr. 9, Juli 2016, S. 961-970, doi:10.1080/21678707.2016.1215910, PMC 5380149 (freier Volltext). Abgerufen am 10. Februar 2024.
Full year report 2011, H. Lundbeck A/S, 8. Februar 2012 (PDF).
nih.gov
ncbi.nlm.nih.gov
X. P. Huang u. a.: Mitochondrial involvement in genetically determined transition metal toxicity I. Iron toxicity. In: Chem. Biol. Interact. 2006; 163(1-2), S. 68–76. PMID 16797509
Christian Rummey, John M. Flynn, Louise A. Corben, Martin B. Delatycki, George Wilmot: Scoliosis in Friedreich's ataxia: longitudinal characterization in a large heterogeneous cohort. In: Annals of Clinical and Translational Neurology. Band8, Nr.6, Juni 2021, ISSN2328-9503, S.1239–1250, doi:10.1002/acn3.51352, PMID 33949801.
Elisabetta Soragni und Joel M. Gottesfeld: Translating HDAC inhibitors in Friedrich's ataxia. In: Expert Opinion on Orphan Drugs. Band 4, Nr. 9, Juli 2016, S. 961-970, doi:10.1080/21678707.2016.1215910, PMC 5380149 (freier Volltext). Abgerufen am 10. Februar 2024.
Christian Rummey, John M. Flynn, Louise A. Corben, Martin B. Delatycki, George Wilmot: Scoliosis in Friedreich's ataxia: longitudinal characterization in a large heterogeneous cohort. In: Annals of Clinical and Translational Neurology. Band8, Nr.6, Juni 2021, ISSN2328-9503, S.1239–1250, doi:10.1002/acn3.51352, PMID 33949801.